2021 Biotech Stock Picking Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2021 Biotech Stock Picking Charity Contest

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

xr1

To: Bladerunner17 who wrote (233)	10/22/2021 10:47:42 AM
From: Thehammer	1 Recommendation of 307

Ocular Therapeutix posts topline results from mid-stage OTX-CSI dry eye disease trial \| Seeking Alpha ^^ Ocular Therapeutix (NASDAQ: OCUL) posts disappointing topline results from its Phase 2 trial of OTX-CSI (cyclosporine intracanalicular insert) for the treatment of dry eye disease (DED).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next